drugset / Trial / NCT02522039

Pupillary Response After Glaucoma Medication

NCT02522039

RandomizedCrossoverQuadruple-blindBasic science

Summary

Investigation of the effect on the pupillary constriction by latanoprost, dorzolamide,timolol in healthy subjects. The pupillary constriction is compared to no drug.

Timeline

Start
2014-05
Primary completion
2014-11
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Dorzolamide Small molecule 20 mg/ml Topical
Subject Latanoprost Small molecule 50 ug/ml Topical
Subject Timolol Other / unclassified 5 mg/ml Topical

Indications